Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease ?

Research output: Contribution to journalArticleResearchpeer-review

1 Downloads (Pure)

Abstract

This scientific commentary refers to 'Distinct brain pathologies associated with Alzheimer's disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis' by Hirota et al. (https://doi.org/10.1093/braincomms/fcac286) and 'Predictive blood biomarkers and brain changes associated with age-related cognitive decline' by Saunders et al. (https://doi.org/10.1093/braincomms/fcad113).

Original languageEnglish
Article numberfcad142
Pages (from-to)1-4
Number of pages4
JournalBrain Communications
Volume5
Issue number3
DOIs
Publication statusPublished - 27 Apr 2023

Fingerprint

Dive into the research topics of 'Is phosphorylated tau a good biomarker of synapse pathology in Alzheimer’s disease ?'. Together they form a unique fingerprint.

Cite this